ATOMOXETINE HCL 25 MG CAPSULE
For 30 capsules
Pharmacies pay
$11.49 filed
30 × $0.38297 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$68.19 filed
30 × $2.27304 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
5.9× estimated
Medicare paid 5.9× what pharmacies pay.
Part D averages every strength and form sold under “Atomoxetine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$18.21 estimated
$11.49 + $1.72 (15%) + $5.00 fee per fill = $18.21
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ATOMOXETINE HCL 25 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “atomoxetine” and “atomoxetine hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as capsule and its route as oral.
FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Northstar Rx LLC and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Norepinephrine Reuptake Inhibitor.
The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes); the FDA directory lists 11 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $11.49 for 30 capsules (30 × $0.38297 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 capsules · NADAC explanation codes
The 11 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| American Health Packaging | 1 | $0.38297 per EA filed |
| Apotex Corp. | 1 | $0.38297 per EA filed |
| AvPAK | 1 | $0.38297 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.38297 per EA filed |
| Dr. Reddy's Laboratories Limited | 1 | $0.38297 per EA filed |
| Glenmark Pharmaceuticals Inc., USA | 1 | $0.38297 per EA filed |
| NorthStar RxLLC | 1 | $0.38297 per EA filed |
| Northstar Rx LLC | 1 | $0.38297 per EA filed |
| Rising Pharma Holdings, Inc. | 1 | $0.38297 per EA filed |
| Strides Pharma Science Limited | 1 | $0.38297 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 1 | $0.38297 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.38297 per EA filed |
All 13 NDCs, with labeler and price
- 00093-3544-56 · Teva Pharmaceuticals USA, Inc. · $0.38297 per EA · eff. 2026-09-23 filed
- 16714-0757-01 · Northstar Rx LLC · $0.38297 per EA · eff. 2026-09-23 filed
- 31722-0716-30 · Camber Pharmaceuticals, Inc. · $0.38297 per EA · eff. 2026-09-23 filed
- 50268-0057-11 · not listed as a package in the FDA directory · $0.38297 per EA · eff. 2026-09-23 filed
- 50268-0057-13 · AvPAK · $0.38297 per EA · eff. 2026-09-23 filed
- 55111-0528-30 · Dr. Reddy's Laboratories Limited · $0.38297 per EA · eff. 2026-09-23 filed
- 60505-2832-03 · Apotex Corp. · $0.38297 per EA · eff. 2026-09-23 filed
- 60687-0567-11 · not listed as a package in the FDA directory · $0.38297 per EA · eff. 2026-09-23 filed
- 60687-0567-21 · American Health Packaging · $0.38297 per EA · eff. 2026-09-23 filed
- 64380-0474-01 · Strides Pharma Science Limited · $0.38297 per EA · eff. 2026-09-23 filed
- 64980-0375-03 · Rising Pharma Holdings, Inc. · $0.38297 per EA · eff. 2026-09-23 filed
- 68462-0267-30 · Glenmark Pharmaceuticals Inc., USA · $0.38297 per EA · eff. 2026-09-23 filed
- 72603-0437-01 · NorthStar RxLLC · $0.38297 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
6 other products in the NADAC file share an FDA nonproprietary name with ATOMOXETINE HCL 25 MG CAPSULE.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ATOMOXETINE HCL 10 MG CAPSULE | $0.32216 per EA filed | $2.27304 per EA filed |
| ATOMOXETINE HCL 18 MG CAPSULE | $0.38181 per EA filed | $2.27304 per EA filed |
| ATOMOXETINE HCL 25 MG CAPSULE this page | $0.38297 per EA filed | $2.27304 per EA filed |
| ATOMOXETINE HCL 40 MG CAPSULE | $0.44218 per EA filed | $2.27304 per EA filed |
| ATOMOXETINE HCL 60 MG CAPSULE | $0.50934 per EA filed | $2.27304 per EA filed |
| ATOMOXETINE HCL 80 MG CAPSULE | $0.52256 per EA filed | $2.27304 per EA filed |
| ATOMOXETINE HCL 100 MG CAPSULE | $0.51448 per EA filed | $2.27304 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 13 NDCs’ NADAC prices is $0.38297 per EA filed.
Of the 9 other products in FDA’s Norepinephrine Reuptake Inhibitor class priced per EA, 7 have a higher middle NADAC price and 2 a lower one. The one in the middle is ATOMOXETINE HCL 100 MG CAPSULE, at $0.51448 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $68.19 for 30 capsules, at an average of $2.27304 per EA in 2024 (2024-01-01 to 2024-12-31) for “Atomoxetine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 325,761 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for ATOMOXETINE HCL 25 MG CAPSULE labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Atomoxetine HCl / Atomoxetine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.